[45] Toxicity of protein aggregates in PC12 cells: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay
- 1 January 1999
- book chapter
- Published by Elsevier
- Vol. 309, 716-723
- https://doi.org/10.1016/s0076-6879(99)09047-3
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The toxicity in vitro of β-amyloid proteinBiochemical Journal, 1995
- The Intracellular Component of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction Is Specifically Inhibited by β‐Amyloid PeptidesJournal of Neurochemistry, 1995
- Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitusNature, 1994
- Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal culturesEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Use of an Aqueous Soluble Tetrazolium/Formazan Assay for Cell Growth Assays in CultureCancer Communications, 1991
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.Journal of Histochemistry & Cytochemistry, 1989
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989
- Molecular genetic approaches to Alzheimer's diseaseTrends in Neurosciences, 1989
- Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer's diseaseNeuroscience Letters, 1985